MPP partnered with the State of Texas offering monoclonal antibody infusion treatments from January 2021 through April 2021
Infusion Pumps to administer Covid-19 treatments. (Credit: Pete Linforth from Pixabay.)
Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that MPP Infusion Centers® (Multispeciality Physician Partners), a Joint Commission-accredited ambulatory infusion services provider, has broadened its use of Eitan Medical’s flagship Sapphire infusion pump to administer COVID-19 monoclonal antibody infusion treatments to COVID-19 patients.
Monoclonal antibodies – laboratory-made proteins designed to mimic the antibodies generated naturally by the immune system to fend off viruses – have been shown to provide an effective therapeutic intervention in treating specific diseases. Earlier this year, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) of specific monoclonal antibodies for the treatment of COVID-19.
As one of the first infusion centers in the country to successfully administer COVID-19 antibody therapies, MPP partnered with the State of Texas offering monoclonal antibody infusion treatments from January 2021 through April 2021. Beyond COVID-19 care, MPP uses Sapphire pumps for all biological treatments, as the Sapphire provides a single solution for multiple therapies with intuitive and easy point-of-care programming, allowing staff to efficiently oversee and treat multiple patients simultaneously.
“At MPP Infusion Centers, we stress the importance of continuing to provide our patients with exceptional, safe, and expert care during the pandemic,” said Aaron Bangsund, Senior Director Market Development at MPP. “Sapphire provides high accuracy with built-in safety mechanisms; using a trusted device like Sapphire is critical in the treatment of high-risk COVID-19 patients.”
“Eitan Medical is a patient-centric company, with the patient’s care, comfort and safety always at the center of its technology; Sapphire is the natural fit for MPP Infusion Centers, which focus on compassionate care,” said Roger Massengale, CCO Medication Delivery Solutions at Eitan Medical. “We appreciate MPP’s confidence and trust in our products to support their COVID-19 patients, who need advanced levels of care and reassurance at this crucial time in their care journey.”
Eitan Medical’s flagship Sapphire infusion pump is the solution of choice for infusion centers—with a compact and lightweight design, low total cost of ownership, advanced fleet maintenance solutions and future-ready, software driven technology. The Sapphire’s smart technology includes a full color touch screen for intuitive and fast operation, an easy to use on-screen alarm troubleshooter and built-in safety mechanisms aimed to enhance patient care.
Source: Company Press Release